Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

GlaxoSmithKline Pharmaceuticals Ltd.

  • NSE: GLAXO

  • BSE: 500660

  • Q
  • V
  • T
  • Expensive Star
72.80/100

Quality Score

High Financial Strength
3.67/100

Valuation Score

Expensive Valuation
67.57/100

Technical Score

Technically Moderately Bullish
Broker Average Rating

2.00

Broker Average Rating

MFI

77.72

MFI Overbought

50Day SMA Rs

1542.93 Rs

Price above SMA 1542.93

Quality score

72.80

High Financial Strength

30Day SMA Rs

1581.13 Rs

Price above SMA 1581.13

Broker Covering stock

2.00

2 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

3.00

3 Broker 6M Target downgrade

Momentum score

67.57

Technically Moderately Bullish

Price to Book Ratio

15.80

High in industry

Broker Reports in 1Yr

6.00

6 Broker Reports in 1Yr

TTM PE Ratio

317.87

Market Runner Up

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

77.91

RSI Overbought

Net Profit Qtr Cr

110.83 Cr

High in industry

Operating Revenues Qtr Cr

648.59 Cr

High in industry

MACD

64.50

MACD above Signal and Center

Valuation score

3.67

Expensive Valuation

MACD Signal Line

48.08

MACD above Signal and Center

FII holding holding %

0.23 %

FII holding decreased by 0.07%.

Promoter holding holding %

75.00 %

No change in Promoter holding

MF holding holding %

4.81 %

MF holding increased by 0.2%.

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

1479.51 Rs

Price above SMA 1479.51

Institutions holding holding %

12.35 %

Institutions holding increased by 0.68%.

200Day SMA Rs

1471.70 Rs

Price above SMA 1471.7

NSE GLAXO
1697.90
  • 1763.50 Close
  • 1777.00 Open
  • 8.59 Lk Volume
Today Low/High
Low 1661.00
High 1790.00
52 Week Low/High
13-03-2020 962.65
15-09-2020 1807.50

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
GlaxoSmithKline Pharmaceuticals Ltd. 1697.9 317.87 28764.12 2.35 110.83 0 648.59 -17.69 15.79
Sun Pharmaceutical Industries Ltd. 523.35 491.26 125567.36 0.76 -2429.81 0 7585.25 -9.43 2.55
Divi's Laboratories Ltd. 3344.4 55.61 88777.09 0.47 492.06 0 1730.47 48.8 12.14
Dr. Reddy's Laboratories Ltd. 5333.35 46.73 88640.27 0.46 586.9 0 4426.5 14.72 5.68
Cipla Ltd. 806.25 39.44 65003.9 0.49 571.42 0 4346.16 8.95 4.04
Lupin Ltd. 1085.9 -105.29 49202.12 0.55 108.14 0 3527.86 -20.16 3.91
Torrent Pharmaceuticals Ltd. 2876.3 43.07 48678.5 1.11 321 0 2056 1.68 10.09
Aurobindo Pharma Ltd. 828.1 16.13 48518.37 0.51 792.68 0 5924.78 8.81 2.88